KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2021
Related Segments
Latin America PACS 2024
A Look at Vendor Performance in an Evolving Market
Author
Eder Lagemann
Author
Jonathan Christensen
Author
Chloe Jensen
The PACS market in Latin America is evolving—vendors have expanded or reestablished their customer bases in certain countries, and some healthcare organizations are considering replacing products that aren’t meeting expectations. An update to KLAS’ 2021 research, this report examines vendors’ regional footprint and performance in Latin America. Altogether, customer satisfaction feedback was collected from 127 respondents, representing 95 separate organizations in 12 countries and territories. Insights are examined first for Latin America as a whole, then for Brazil, and then for other countries throughout the region, collectively referred to as “other Latin American countries and the Caribbean.”
If you don't have a login, getting started is easy.
Key Findings
- Fujifilm, Pixeon & AGFA HealthCare Perform Best Overall; Philips Most Used by Large Organizations
- Customer Dissatisfaction with GE HealthCare, MV & Philips Leads Some to Consider Other Options
- Pixeon & Fujifilm Stand Out for Strong Support & Reliability
- Philips & MV Customers Frustrated with Pricing, Especially for Updates
- AGFA HealthCare Highlighted for Support, Ease of Use & Reliability
- Philips Customers Concerned with Slow Development; GE HealthCare Customers Frustrated with Support
Writer
Sarah Brown
Designer
Jess Wallace-Simpson
Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.